The Effect of High Dose N-acetylcysteine on Airtrapping and Airway Resistance in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01136239 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

133

Enrollment

OTHER

Sponsor class

Conditions

COPD

Interventions

DRUG: N-acetycysteine (600mg twice daily)
DRUG: Placebo

Sponsor

Kwong Wah Hospital